Published in

Springer Nature [academic journals on nature.com], British Journal of Cancer, 8(104), p. 1356-1361, 2011

DOI: 10.1038/bjc.2011.91

Links

Tools

Export citation

Search in Google Scholar

Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2

Journal article published in 2011 by M. F. van Dooren, A. (Ana) Osorio, R. Alonso, Roger L. (Roger) Milne, T. Rebbeck, S. (Senno) Verhoef, C. R. (Carmen) Pallás-Alonso, Cj J. van Asperen, G. (G.) Pita, Milne Rl, Fb B. L. (Frans) Hogervorst, M. P. (Maaike) Vreeswijk, Ce E. Van Roozendaal, P. (Paolo) Peterlongo, Q. (Quinten) Waisfisz and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Background: Single-nucleotide polymorphisms (SNPs) in genes involved in DNA repair are good candidates to be tested as phenotypic modifiers for carriers of mutations in the high-risk susceptibility genes BRCA1 and BRCA2. The base excision repair (BER) pathway could be particularly interesting given the relation of synthetic lethality that exists between one of the components of the pathway, PARP1, and both BRCA1 and BRCA2. In this study, we have evaluated the XRCC1 gene that participates in the BER pathway, as phenotypic modifier of BRCA1 and BRCA2. Methods: Three common SNPs in the gene, c.-77C>T (rs3213245) p.Arg280His (rs25489) and p.Gln399Arg (rs25487) were analysed in a series of 701 BRCA1 and 576 BRCA2 mutation carriers. Results: An association was observed between p.Arg280His-rs25489 and breast cancer risk for BRCA2 mutation carriers, with rare homozygotes at increased risk relative to common homozygotes (hazard ratio: 22.3, 95% confidence interval: 14.3–34, P